These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 9654389)
1. Platelet-activating factor antagonism: a new concept in the management of regional myocardial ischemia-reperfusion injury. Loucks EB; Symersky P; Qayumi AK J Invest Surg; 1997; 10(6):321-38. PubMed ID: 9654389 [TBL] [Abstract][Full Text] [Related]
2. The role of platelet-activating factor in regional myocardial ischemia-reperfusion injury. Qayumi AK; English JC; Godin DV; Ansley DM; Loucks EB; Lee JU; Kim CW Ann Thorac Surg; 1998 Jun; 65(6):1690-7. PubMed ID: 9647083 [TBL] [Abstract][Full Text] [Related]
3. Role of platelet activating factor in cardiac dysfunction, apoptosis and nitric oxide synthase mRNA expression in the ischemic-reperfused rabbit heart. Loucks EB; Godin DV; Walley KR; McManus BM; Rahimian R; Granville DJ; Hong JM; Aktary FM; Qayumi AK Can J Cardiol; 2003 Mar; 19(3):267-74. PubMed ID: 12677282 [TBL] [Abstract][Full Text] [Related]
4. Inhibition of platelet-activating factor fails to limit ischemia and reperfusion-induced myocardial damage. Black SC; Driscoll EM; Lucchesi BR J Cardiovasc Pharmacol; 1992 Dec; 20(6):997-1005. PubMed ID: 1282605 [TBL] [Abstract][Full Text] [Related]
5. Therapeutic potential of platelet-activating factor antagonism in the management of myocardial infarction. Loucks EB; Qayumi AK; Godin DV; English JC; Lim SP; Al Mahmeed T; Gul S Can J Cardiol; 2000 Apr; 16(4):497-504. PubMed ID: 10787465 [TBL] [Abstract][Full Text] [Related]
6. Evidence for a role of platelet activating factor in the pathogenesis of irreversible but not reversible myocardial injury after reperfusion in dogs. Maruyama M; Farber NE; Vercellotti GM; Jacob HS; Gross GJ Am Heart J; 1990 Sep; 120(3):510-20. PubMed ID: 2389687 [TBL] [Abstract][Full Text] [Related]
7. Effects of the PAF antagonists BN50726 and BN50739 on arrhythmogenesis and extent of necrosis during myocardial ischaemia/reperfusion in rabbits. Chakrabarty S; Fluck DS; Flores NA; Sheridan DJ Br J Pharmacol; 1992 Nov; 107(3):705-9. PubMed ID: 1472967 [TBL] [Abstract][Full Text] [Related]
8. Platelet activating factor: the good and the bad in the ischemic/reperfused heart. Penna C; Bassino E; Alloatti G Exp Biol Med (Maywood); 2011 Apr; 236(4):390-401. PubMed ID: 21378031 [TBL] [Abstract][Full Text] [Related]
10. Platelet-activating factor antagonism attenuates platelet and neutrophil activation and reduces myocardial injury during coronary reperfusion. Ko W; Lang D; Hawes AS; Zelano JA; Isom OW; Krieger KH J Surg Res; 1993 Nov; 55(5):504-15. PubMed ID: 8231170 [TBL] [Abstract][Full Text] [Related]
11. Effect of the platelet-activating factor antagonist RP 59227 (Tulopafant) on myocardial ischemia/reperfusion injury and neutrophil function. Auchampach JA; Pieper GM; Cavero I; Gross GJ Basic Res Cardiol; 1998 Oct; 93(5):361-71. PubMed ID: 9833148 [TBL] [Abstract][Full Text] [Related]
12. Platelet activating factor interaction with tumor necrosis factor in myocardial ischaemia-reperfusion injury. Squadrito F; Ioculano M; Altavilla D; Zingarelli B; Canale P; Campo GM; Saitta A; Calapai G; Bussolino F; Caputi AP J Lipid Mediat; 1993 Aug; 8(1):53-65. PubMed ID: 8257777 [TBL] [Abstract][Full Text] [Related]
13. Do platelets protect the heart against ischemia/reperfusion injury or exacerbate cardiac ischemia/reperfusion injury? The role of PDGF, VEGF, and PAF. Voronkov NS; Maslov LN; Vyshlov EV; Mukhomedzyanov AV; Ryabov VV; Derkachev IA; Kan A; Gusakova SV; Gombozhapova AE; Panteleev OO Life Sci; 2024 Jun; 347():122617. PubMed ID: 38608835 [TBL] [Abstract][Full Text] [Related]
14. Induction of tissue injury and altered cardiovascular performance by platelet-activating factor: relevance to multiple systems organ failure. Lefer AM Crit Care Clin; 1989 Apr; 5(2):331-52. PubMed ID: 2650821 [TBL] [Abstract][Full Text] [Related]